TERN logo

Terns Pharmaceuticals, Inc. (TERN) Cash From Operations

Annual CFO:

-$70.02M-$2.63M(-3.90%)
December 31, 2024

Summary

  • As of today, TERN annual cash from operations is -$70.02 million, with the most recent change of -$2.63 million (-3.90%) on December 31, 2024.
  • During the last 3 years, TERN annual cash from operations has fallen by -$28.19 million (-67.39%).
  • TERN annual cash from operations is now -287.45% below its all-time high of -$18.07 million, reached on December 31, 2018.

Performance

TERN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNcash flow metrics

Quarterly CFO:

-$19.77M-$899.00K(-4.76%)
September 30, 2025

Summary

  • As of today, TERN quarterly cash from operations is -$19.77 million, with the most recent change of -$899.00 thousand (-4.76%) on September 30, 2025.
  • Over the past year, TERN quarterly cash from operations has dropped by -$3.24 million (-19.62%).
  • TERN quarterly cash from operations is now -171.35% below its all-time high of -$7.29 million, reached on March 31, 2020.

Performance

TERN Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNcash flow metrics

TTM CFO:

-$77.99M-$3.24M(-4.34%)
September 30, 2025

Summary

  • As of today, TERN TTM cash from operations is -$77.99 million, with the most recent change of -$3.24 million (-4.34%) on September 30, 2025.
  • Over the past year, TERN TTM cash from operations has dropped by -$3.17 million (-4.23%).
  • TERN TTM cash from operations is now -970.26% below its all-time high of -$7.29 million, reached on March 31, 2020.

Performance

TERN TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TERN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-3.9%-19.6%-4.2%
3Y3 Years-67.4%-45.6%-51.6%
5Y5 Years-5.7%--

TERN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-67.4%at low-72.4%+19.1%-57.5%+1.3%
5Y5-Year-134.9%at low-144.7%+19.1%-384.1%+1.3%
All-TimeAll-Time-287.4%at low-171.3%+19.1%-970.3%+1.3%

TERN Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$19.77M(-4.8%)
-$77.99M(-4.3%)
Jun 2025
-
-$18.87M(+22.8%)
-$74.75M(-3.7%)
Mar 2025
-
-$24.45M(-64.1%)
-$72.05M(-2.3%)
Dec 2024
-$70.02M(-3.9%)
-$14.90M(+9.9%)
-$70.40M(+5.9%)
Sep 2024
-
-$16.53M(-2.2%)
-$74.82M(+5.3%)
Jun 2024
-
-$16.18M(+29.0%)
-$78.99M(-4.2%)
Mar 2024
-
-$22.80M(-18.0%)
-$75.81M(-11.9%)
Dec 2023
-$67.39M(-37.2%)
-$19.32M(+6.7%)
-$67.73M(-13.1%)
Sep 2023
-
-$20.70M(-59.3%)
-$59.89M(-13.5%)
Jun 2023
-
-$12.99M(+11.8%)
-$52.77M(-3.6%)
Mar 2023
-
-$14.73M(-28.4%)
-$50.94M(-2.9%)
Dec 2022
-$49.11M
-$11.47M(+15.6%)
-$49.51M(+3.7%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$13.58M(-21.7%)
-$51.43M(-12.0%)
Jun 2022
-
-$11.16M(+16.1%)
-$45.93M(-5.5%)
Mar 2022
-
-$13.30M(+0.7%)
-$43.53M(+2.3%)
Dec 2021
-$41.83M(-40.3%)
-$13.39M(-65.7%)
-$44.55M(-43.0%)
Sep 2021
-
-$8.08M(+7.7%)
-$31.16M(-35.0%)
Jun 2021
-
-$8.76M(+38.8%)
-$23.08M(+0.3%)
Mar 2021
-
-$14.32M(-62.3%)
-$23.14M(-43.6%)
Dec 2020
-$29.81M(+55.0%)
-
-
Jun 2020
-
-$8.82M(-21.1%)
-$16.11M(-121.1%)
Mar 2020
-
-$7.29M
-$7.29M
Dec 2019
-$66.22M(-266.5%)
-
-
Dec 2018
-$18.07M
-
-

FAQ

  • What is Terns Pharmaceuticals, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. annual cash from operations year-on-year change?
  • What is Terns Pharmaceuticals, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
  • What is Terns Pharmaceuticals, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

What is Terns Pharmaceuticals, Inc. annual cash from operations?

The current annual cash from operations of TERN is -$70.02M

What is the all-time high annual cash from operations for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high annual cash from operations is -$18.07M

What is Terns Pharmaceuticals, Inc. annual cash from operations year-on-year change?

Over the past year, TERN annual cash from operations has changed by -$2.63M (-3.90%)

What is Terns Pharmaceuticals, Inc. quarterly cash from operations?

The current quarterly cash from operations of TERN is -$19.77M

What is the all-time high quarterly cash from operations for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high quarterly cash from operations is -$7.29M

What is Terns Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?

Over the past year, TERN quarterly cash from operations has changed by -$3.24M (-19.62%)

What is Terns Pharmaceuticals, Inc. TTM cash from operations?

The current TTM cash from operations of TERN is -$77.99M

What is the all-time high TTM cash from operations for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high TTM cash from operations is -$7.29M

What is Terns Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

Over the past year, TERN TTM cash from operations has changed by -$3.17M (-4.23%)
On this page